Stay updated on GLPG2222 in Ivacaftor-treated CF: Clinical Trial
Sign up to get notified when there's something new on the GLPG2222 in Ivacaftor-treated CF: Clinical Trial page.

Latest updates to the GLPG2222 in Ivacaftor-treated CF: Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision updated from v3.6.2 to v3.6.3, signaling a minor site update. This change represents an internal revision label and does not modify the study details shown on the page.SummaryDifference0.0%

- Check15 days agoChange DetectedRevision label updated from v3.6.0 to v3.6.2 on the page, indicating a newer revision of the page content. This change does not modify the study data or user-facing information.SummaryDifference0.0%

- Check29 days agoChange DetectedThe study page now indicates that recruitment is closed. Additionally, new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) were added, and there are minor heading/version label updates indicating formatting changes.SummaryDifference0.4%

- Check36 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, indicating a minor update to the page version rather than a modification to the study content.SummaryDifference0.0%

- Check51 days agoChange DetectedThe sponsor field now lists Lakefront Biotherapeutics NV instead of Galapagos NV. This reflects a transition of sponsorship for the study.SummaryDifference0.2%

- Check58 days agoChange DetectedThe page's revision label updates from v3.5.3 to v3.5.4, reflecting an update to the page's backend or UI. This change does not alter the study details, eligibility, locations, or outcomes.SummaryDifference0.0%

Stay in the know with updates to GLPG2222 in Ivacaftor-treated CF: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG2222 in Ivacaftor-treated CF: Clinical Trial page.